Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Debt Ratio (2016 - 2023)

Arcadia Biosciences filings provide 10 years of Debt Ratio readings, the most recent being 0.0 for Q1 2023.

  • On a quarterly basis, Debt Ratio fell 72.26% to 0.0 in Q1 2023 year-over-year; TTM through Mar 2023 was 0.0, a 72.26% decrease, with the full-year FY2022 number at 0.0, up 13.89% from a year prior.
  • Debt Ratio hit 0.0 in Q1 2023 for Arcadia Biosciences, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.09 in Q2 2020 to a low of 0.0 in Q1 2023.
  • Median Debt Ratio over the past 5 years was 0.0 (2022), compared with a mean of 0.02.
  • Biggest five-year swings in Debt Ratio: skyrocketed 11415.1% in 2020 and later crashed 97.14% in 2021.
  • Arcadia Biosciences' Debt Ratio stood at 0.0 in 2019, then skyrocketed by 922.59% to 0.05 in 2020, then tumbled by 96.84% to 0.0 in 2021, then increased by 13.89% to 0.0 in 2022, then plummeted by 70.28% to 0.0 in 2023.
  • The last three reported values for Debt Ratio were 0.0 (Q1 2023), 0.0 (Q4 2022), and 0.0 (Q3 2022) per Business Quant data.